Cargando…
miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis
Identification of dysregulated microRNAs (miRNAs) in prostate cancer is critical not only for diagnosis, but also differentiation between the aggressive and indolent forms of the disease. miR-9 was identified as an oncomiR through both miRNA panel RT-qPCR as well as high-throughput sequencing analys...
Autores principales: | Seashols-Williams, S. J., Budd, W., Clark, G. C., Wu, Q., Daniel, R., Dragoescu, E., Zehner, Z. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957825/ https://www.ncbi.nlm.nih.gov/pubmed/27447934 http://dx.doi.org/10.1371/journal.pone.0159601 |
Ejemplares similares
-
Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis
por: Budd, William T., et al.
Publicado: (2015) -
OMCD: OncomiR Cancer Database
por: Sarver, Aaron L., et al.
Publicado: (2018) -
miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma
por: Liang, Hongwei, et al.
Publicado: (2016) -
miR-128 Functions as an OncomiR for the Downregulation of HIC1 in Breast Cancer
por: Li, Yan, et al.
Publicado: (2019) -
OncomiR-17-5p: alarm signal in cancer?
por: Bobbili, Madhusudhan Reddy, et al.
Publicado: (2017)